Tag: Regulatory

Dublin, July 08, 2025 (GLOBE NEWSWIRE) -- The "Brazil Cement Industry Market Size & Forecast by Value and Volume Across 80+ Market Segments by Cement Products, Distribution Channel, Market Share, Import - Export, End Markets - Databook Q2 2025 Update" report has been added to ResearchAndMarkets.com's offering.

The cement market in Brazil is expected to grow by 7.6% annually to reach US$6.43 billion in 2025. The cement market in the country recorded strong growth during 2020-2024, achieving a CAGR of 8.8%. Growth momentum is expected to remain positive, with the market projected to expand at a CAGR of 7.1% during 2025-2029. By the end of 2029, the cement market is projected to expand from its 2024 value of US$5.98 billion to approximately US$8.47 billion.

Broadband speeds up to 5 Gbps will be available in the towns of New Market and Walkersville, Maryland

Florida, July 08, 2025 (GLOBE NEWSWIRE) -- Slate, a leading innovation discovery platform developed by GreyB, has announced the launch of “Prism", a new structured research module to solve complex, constraint-based R&D challenges. Slate Prism breaks down your query, scans thousands of patents and papers, and delivers evidence-backed insights on what works, what doesn’t, and why. It goes beyond simple search results to deliver in-depth analysis of solutions.

FORM 8.3

Corbion, a global leader in sustainable ingredient solutions, has successfully secured multiple regulatory approvals from China’s General Administration of Customs (GACC) paving the way for offering Corbion’s high quality, sustainable, algae-derived omega-3 DHA solutions in China’s fast-growing human and animal nutrition segments.

FORM 8.3

SINGAPORE, July 08, 2025 (GLOBE NEWSWIRE) -- Valeura Energy Inc. (TSX:VLE, OTCQX:VLERF) (“Valeura” or the “Company”) is pleased to provide an update on Q2 2025 operations.

Exhale Wellness launches its new line of Delta 9 Gummies - Bottle Caps. Learn about the product - ingredients, flavors, lab tests, etc. Read User Reviews

Basel, July 8, 2025 – Novartis today announced Coartem^® (artemether-lumefantrine) Baby has been approved by Swissmedic as the first malaria medicine for newborns and young infants. The new treatment, also known as Riamet^® Baby in some countries, was developed in collaboration with Medicines for Malaria Venture (MMV) to treat the potentially deadly mosquito-borne disease.